Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs.

cancer therapy drug delivery electroporation exosome hepatocarcinoma miR-31 miR-451a miRNA enrichment miRNA loading vesicle engineering

Journal

Molecular therapy. Methods & clinical development
ISSN: 2329-0501
Titre abrégé: Mol Ther Methods Clin Dev
Pays: United States
ID NLM: 101624857

Informations de publication

Date de publication:
14 Jun 2019
Historique:
received: 19 11 2018
accepted: 03 01 2019
entrez: 22 2 2019
pubmed: 23 2 2019
medline: 23 2 2019
Statut: epublish

Résumé

Extracellular vesicles (EVs) carry various molecules involved in intercellular communication and have raised great interest as drug delivery systems. Several engineering methods have been investigated for vesicle loading. Here, we studied the electroporation of EVs isolated from plasma to load antitumor microRNAs (miRNAs). First, we optimized the transfection protocol using miRNA cel-39 by evaluating different parameters (voltage and pulse) for their effect on vesicle morphology, loading capacity, and miRNA transfer to target cells. When compared with direct incubation of EVs with miRNA, mild electroporation allowed more efficient loading and better protection of miRNA from RNase degradation. Moreover, electroporation preserved the naive vesicle cargo, including RNAs and proteins, and their ability to be taken up by target cells, supporting the absence of vesicle damage. EVs engineered with antitumor miRNAs (miR-31 and miR-451a) successfully promoted apoptosis of the HepG2 hepatocellular carcinoma cell line, silencing target genes involved in anti-apoptotic pathways. Our findings indicate an efficient and functional miRNA encapsulation in plasma-derived EVs following an electroporation protocol that preserves EV integrity.

Identifiants

pubmed: 30788382
doi: 10.1016/j.omtm.2019.01.001
pii: S2329-0501(19)30004-X
pmc: PMC6370572
doi:

Types de publication

Journal Article

Langues

eng

Pagination

133-144

Références

FASEB J. 2003 Jun;17(9):1159-61
pubmed: 12709414
Biochem Pharmacol. 2008 Sep 1;76(5):582-8
pubmed: 18619946
PLoS One. 2008;3(11):e3694
pubmed: 19002258
Brain Res. 2010 Nov 4;1359:14-21
pubmed: 20816946
Oncogene. 2011 Jun 9;30(23):2644-58
pubmed: 21358675
Nucleic Acids Res. 2012 Sep 1;40(17):e130
pubmed: 22618874
Stem Cells. 2012 Sep;30(9):1985-98
pubmed: 22736596
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2110-6
pubmed: 22753494
RNA. 2013 Jun;19(6):737-9
pubmed: 23554231
BMC Genomics. 2013 May 10;14:319
pubmed: 23663360
J Control Release. 2013 Nov 28;172(1):229-238
pubmed: 23994516
Annu Rev Pathol. 2014;9:287-314
pubmed: 24079833
Anal Biochem. 2014 Mar 1;448:41-9
pubmed: 24333249
Biomaterials. 2014 Feb;35(7):2383-90
pubmed: 24345736
Int J Oncol. 2014 Jun;44(6):2034-40
pubmed: 24647772
Biochem Biophys Res Commun. 2014 Apr 18;446(4):1165-71
pubmed: 24667602
J Extracell Vesicles. 2014 Mar 26;3:null
pubmed: 24683445
Annu Rev Biomed Eng. 2014 Jul 11;16:295-320
pubmed: 24905876
J Extracell Vesicles. 2014 Aug 04;3:null
pubmed: 25143819
Tumour Biol. 2014 Dec;35(12):12593-9
pubmed: 25201065
Cancer Biol Ther. 2014;15(11):1444-55
pubmed: 25482951
J Control Release. 2015 May 10;205:35-44
pubmed: 25483424
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Oncotarget. 2015 Apr 10;6(10):8089-102
pubmed: 25797269
J Control Release. 2015 Jun 10;207:18-30
pubmed: 25836593
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Oncotarget. 2015 Jul 30;6(21):18613-30
pubmed: 26164082
Int J Clin Exp Pathol. 2015 Jun 01;8(6):6995-7001
pubmed: 26261589
Mol Pharm. 2015 Oct 5;12(10):3650-7
pubmed: 26376343
Med Sci Monit. 2015 Oct 30;21:3291-7
pubmed: 26516138
Cytotechnology. 2016 Oct;68(5):2125-38
pubmed: 26856590
Urology. 2016 May;91:241.e1-7
pubmed: 26876462
Oncotarget. 2016 Jun 14;7(24):36577-36589
pubmed: 27174918
Int J Oncol. 2016 Jul;49(1):5-32
pubmed: 27175518
Mol Ther. 2016 Oct;24(10):1836-1847
pubmed: 27506293
J Control Release. 2016 Dec 10;243:160-171
pubmed: 27742443
Cell Mol Bioeng. 2016 Sep;9(3):315-324
pubmed: 27800035
Oncotarget. 2016 Dec 27;7(52):86675-86686
pubmed: 27880727
Am J Physiol Lung Cell Mol Physiol. 2017 Jan 1;312(1):L110-L121
pubmed: 27881406
J Cancer. 2016 Nov 25;7(15):2317-2326
pubmed: 27994670
Biochem Biophys Res Commun. 2017 Jan 29;483(1):630-637
pubmed: 27998765
Inflammation. 2017 Apr;40(2):486-496
pubmed: 28000095
Int J Mol Med. 2016 Nov;38(5):1359-1366
pubmed: 28025988
ACS Nano. 2017 Jan 24;11(1):69-83
pubmed: 28068069
Mol Cancer Ther. 2017 May;16(5):905-913
pubmed: 28167506
Pharmacol Ther. 2017 Jun;174:63-78
pubmed: 28202367
Cancer Biomark. 2017;19(2):221-230
pubmed: 28269758
Mol Ther. 2017 Jul 5;25(7):1580-1587
pubmed: 28392161
Acta Pharmacol Sin. 2017 Jun;38(6):754-763
pubmed: 28392567
Chem Sci. 2017 Feb 1;8(2):1062-1067
pubmed: 28451245
Tissue Eng Part A. 2017 Nov;23(21-22):1262-1273
pubmed: 28471327
Biochem Biophys Res Commun. 2017 Aug 19;490(2):371-377
pubmed: 28623129
Sci Rep. 2017 Jul 20;7(1):5998
pubmed: 28729721
J Circ Biomark. 2015 Jul 17;4:7
pubmed: 28936243
Hepatology. 2018 Apr;67(4):1392-1407
pubmed: 29108133
Int J Nanomedicine. 2018 Jan 30;13:585-599
pubmed: 29430178
Oncotarget. 2017 Nov 9;9(5):5517-5528
pubmed: 29464015
Cell Physiol Biochem. 2018;46(2):757-764
pubmed: 29621773
Am J Cancer Res. 2018 Mar 01;8(3):405-421
pubmed: 29636997
Int J Nanomedicine. 2018 Apr 13;13:2295-2307
pubmed: 29713162
Mol Ther Nucleic Acids. 2018 Jun 1;11:485-493
pubmed: 29858083
Biomed Res Int. 2018 May 22;2018:6784607
pubmed: 29951542

Auteurs

Margherita Alba Carlotta Pomatto (MAC)

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Benedetta Bussolati (B)

Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.

Sergio D'Antico (S)

Blood Bank, A.O.U. Città della Salute e della Scienza, 10126 Turin, Italy.

Sara Ghiotto (S)

Blood Bank, A.O.U. Città della Salute e della Scienza, 10126 Turin, Italy.

Ciro Tetta (C)

Unicyte srl, 10126 Turin, Italy.

Maria Felice Brizzi (MF)

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Giovanni Camussi (G)

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
2i3T Scarl, Univerity of Turin, 10126 Turin, Italy.

Classifications MeSH